Linked Life Data

19963194

Source:http://linkedlifedata.com/resource/pubmed/id/19963194

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2009-12-7
pubmed:abstractText
Cardiovascular disease is the leading cause of death in Western countries. Since 1969, homocysteine has been implicated in the atherosclerotic process, and numerous observational studies have suggested that hyperhomocysteinaemia should be considered as an independent cardiovascular risk factor. B-vitamins, particularly folic acid, reduce homocysteine levels effectively; it was suggested, therefore, that supplementation with these vitamins might decrease cardiovascular risk and reduce the morbidity and mortality associated with stroke, coronary heart disease and peripheral artery disease. However, the results of clinical trials conducted to investigate this issue have been inconsistent. This review discusses the findings of these trials and provides an updated overview on the 'homocysteine hypothesis'.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1875-2128
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
847-54
pubmed:dateRevised
2011-4-25
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
The controversial role of B-vitamins in cardiovascular risk: An update.
pubmed:affiliation
First Propedeutic Department of Internal Medicine, AHEPA Hospital, Aristotle University, S. Kiriakidi 1, 54636, Thessaloniki, Greece. ntaiosgeorge@yahoo.gr
pubmed:publicationType
Journal Article, Review